Search research articles
Contact Us
Filters
Showing results (511-520 of 526) with videos related to
Page
of 53
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 5, 2025
Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxel
Dana M Chase, Jørn Herrstedt, Eirwen M Miller, et al.
The New England Journal of Medicine
|
March 27, 2023
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Mansoor R Mirza, Dana M Chase, Brian M Slomovitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2024
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial
B J Monk, M P Barretina-Ginesta, B Pothuri, et al.
Future Oncology (London, England)
|
July 11, 2024
A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer"
Mansoor R Mirza, Dana M Chase, Brian M Slomovitz, et al.
Brain Computer Interfaces (Abingdon, England)
|
November 21, 2017
Workshops of the Sixth International Brain-Computer Interface Meeting: brain-computer interfaces past, present, and future
Jane E Huggins, Christoph Guger, Mounia Ziat, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
June 7, 2024
A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology
Jay A Lieberman, Derek K Chu, Tasnuva Ahmed, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
November 3, 2024
Corrigendum to 'A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology' [Annals of Allergy, Asthma & Immunology 133/3 (2024) 286-94]
Jay A Lieberman, Derek K Chu, Tasnuva Ahmed, et al.
Nature
|
March 13, 2025
Species turnover does not rescue biodiversity in fragmented landscapes
Thiago Gonçalves-Souza, Jonathan M Chase, Nick M Haddad, et al.
Gynecologic Oncology
|
July 1, 2026
Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer
Mark S Shahin, Domenica Lorusso, Floor J Backes, et al.
Ecology Letters
|
July 9, 2021
Species loss due to nutrient addition increases with spatial scale in global grasslands
Eric W Seabloom, Evan Batzer, Jonathan M Chase, et al.
Page
of 53
Search research articles
Search
Showing results (511-520 of 526) with videos related to
Sort By:
Page
of 53
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 5, 2025
Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxel
Dana M Chase, Jørn Herrstedt, Eirwen M Miller, et al.
The New England Journal of Medicine
|
March 27, 2023
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Mansoor R Mirza, Dana M Chase, Brian M Slomovitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2024
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial
B J Monk, M P Barretina-Ginesta, B Pothuri, et al.
Future Oncology (London, England)
|
July 11, 2024
A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer"
Mansoor R Mirza, Dana M Chase, Brian M Slomovitz, et al.
Brain Computer Interfaces (Abingdon, England)
|
November 21, 2017
Workshops of the Sixth International Brain-Computer Interface Meeting: brain-computer interfaces past, present, and future
Jane E Huggins, Christoph Guger, Mounia Ziat, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
June 7, 2024
A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology
Jay A Lieberman, Derek K Chu, Tasnuva Ahmed, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
November 3, 2024
Corrigendum to 'A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology' [Annals of Allergy, Asthma & Immunology 133/3 (2024) 286-94]
Jay A Lieberman, Derek K Chu, Tasnuva Ahmed, et al.
Nature
|
March 13, 2025
Species turnover does not rescue biodiversity in fragmented landscapes
Thiago Gonçalves-Souza, Jonathan M Chase, Nick M Haddad, et al.
Gynecologic Oncology
|
July 1, 2026
Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer
Mark S Shahin, Domenica Lorusso, Floor J Backes, et al.
Ecology Letters
|
July 9, 2021
Species loss due to nutrient addition increases with spatial scale in global grasslands
Eric W Seabloom, Evan Batzer, Jonathan M Chase, et al.
Page
of 53